###begin article-title 0
###xml 21 27 21 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
Polymorphisms in the PTPN22 region are associated with psoriasis of early onset
###end article-title 0
###begin p 1
Conflicts of interest None declared.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 160 168 <span type="species:ncbi:9606">patients</span>
Psoriasis, a chronic inflammatory skin disease, affects approximately 2% of the population worldwide. Although the aetiology of psoriasis is poorly understood, patients with disease of early onset (Type I, age of onset </= 40 years) usually have a strong genetic component to the disease.
###end p 3
###begin title 4
Objectives
###end title 4
###begin p 5
###xml 111 117 111 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
The purpose of this study was to investigate the role of the protein tyrosine phosphatase nonreceptor type 22 (PTPN22) gene region in susceptibility to Type I psoriasis.
###end p 5
###begin title 6
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients and methods
###end title 6
###begin p 7
###xml 63 69 63 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 99 107 <span type="species:ncbi:9606">patients</span>
Thirteen single nucleotide polymorphisms (SNPs) mapping to the PTPN22 region were genotyped in 647 patients with Type I psoriasis and 566 normal controls.
###end p 7
###begin title 8
Results
###end title 8
###begin p 9
###xml 460 461 460 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 474 475 474 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 578 579 578 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 318 326 <span type="species:ncbi:9606">patients</span>
The rs2476601 (R620W) SNP, widely associated with other inflammatory autoimmune diseases, showed no evidence of association with susceptibility to Type I psoriasis. Two SNPs (rs1217414 and rs3789604) demonstrated significant association with Type I psoriasis and were subsequently genotyped in a further 253 unrelated patients and 2024 normal controls. rs1217414 and rs3789604 were also significantly associated with Type I psoriasis in the combined datasets (P = 0.003 and P = 0.0002, respectively); furthermore carriage of both risk alleles was also significantly associated (P = 0.002).
###end p 9
###begin title 10
Conclusions
###end title 10
###begin p 11
###xml 93 99 93 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
This study demonstrates evidence of association of two SNPs (rs1217414 and rs3789604) in the PTPN22 region with Type I psoriasis, providing evidence for a role of this gene in Type I psoriasis that is not conferred by the R620W variant previously associated with a number of inflammatory diseases.
###end p 11
###begin p 12
###xml 110 111 110 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 480 481 480 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">2</xref>
###xml 774 775 774 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 776 778 776 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 846 852 846 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PSORS1</italic>
###xml 970 971 970 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 1008 1010 1008 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
###xml 1015 1021 1015 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PSORS1</italic>
###xml 1212 1213 1212 1213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">2</xref>
###xml 1225 1231 1225 1231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PSORS1</italic>
###xml 1698 1704 1698 1704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 285 293 <span type="species:ncbi:9606">patients</span>
###xml 677 685 <span type="species:ncbi:9606">patients</span>
###xml 1144 1152 <span type="species:ncbi:9606">patients</span>
###xml 1203 1211 <span type="species:ncbi:9606">patients</span>
Psoriasis is a chronic immune-mediated skin disease that affects approximately 2% of the population worldwide.1 The most common characteristics of the disease are red, well-demarcated and heavily scaled plaques on the knees, elbows and scalp but any skin surface can be affected. Most patients (75%) of chronic plaque psoriasis first present before the age of 40 years - known as early onset or Type I psoriasis. Late onset or Type II psoriasis presents after the age of 40 years.2 Family studies have provided strong evidence that there is an underlying genetic component to Type I psoriasis although the precise mode of inheritance is poorly understood. Genome-wide scans on patients with psoriasis have identified a number of key genomic regions linked to Type I disease.3-12 The best documented of these is psoriasis susceptibility region 1 (PSORS1) situated on chromosome 6p; here 35-50% of the heritability of psoriasis is believed to be attributable to this locus3 with a disease penetrance of 10-15%.13 The PSORS1 susceptibility region harbours the HLA-Cw6 allele which has a strong association with Type I psoriasis; as many as 85% of patients are HLA-Cw6 positive compared with 15% in Type II patients.2 Aside from PSORS1, there is also a significant contribution towards psoriasis susceptibility from non-HLA genes and the identification of these loci are key to understanding the full genetic component that underpins the pathogenesis of the disease. Potential candidate genes can be selected for investigation on the basis of their function or through overlap with related conditions. In particular recent attention has focused on the protein tyrosine phosphatase nonreceptor type 22 (PTPN22) gene.
###end p 12
###begin p 13
###xml 4 10 4 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 208 214 208 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 358 360 358 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 391 393 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 455 457 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 493 495 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 496 498 496 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 499 501 499 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 502 504 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">19</xref>
###xml 529 531 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 532 534 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 676 678 676 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 971 973 971 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 1165 1167 1165 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
The PTPN22 gene encodes the protein lymphoid tyrosine phosphatase (Lyp) which has an N-terminal phosphatase domain and a long, noncatalytic C-terminus with many proline-rich motifs. The R620W polymorphism in PTPN22 is associated with several immune-mediated diseases including rheumatoid arthritis,14-16 Type I diabetes mellitus (initial disease associated),17 juvenile idiopathic arthritis,16 systemic lupus erythematosus15 and autoimmune thyroid disease15 but not others, including psoriasis15,16,18,19 and psoriatic arthritis;16,20 however, speculation regarding the latter remains because of a more recent publication that detected a positive association with this marker.21 This polymorphism is located in the N-terminal proline-rich motif, binding to the src homology 3 binding domain Csk and results in a substitution of arginine with tryptophan. Studies have suggested that the W620 variant has reduced binding to Csk, down-regulating the binding of Lyp with Csk.16 The mechanism(s) underlying the reduced binding are not as yet fully understood, with more recent publications stating that the polymorphism is in fact a gain of function regulator of T cells22 as opposed to a loss of function variant which was the initial hypothesis.
###end p 13
###begin p 14
###xml 22 28 22 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 213 219 213 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 279 281 279 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">19</xref>
###xml 329 335 329 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 636 638 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 703 709 703 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 416 424 <span type="species:ncbi:9606">patients</span>
###xml 766 774 <span type="species:ncbi:9606">patients</span>
Almost all studies of PTPN22 to date have focused on the R620W variant including those failing to find association with psoriasis. However, as activated T cells play a major role in the pathogenesis of psoriasis, PTPN22 remains a strong candidate gene for disease susceptibility.19 Therefore it is possible that polymorphisms in PTPN22 other than R620W may be important in psoriasis. A study of rheumatoid arthritis patients screened multiple single nucleotide polymorphisms (SNPs) across the gene and identified associations independent of R620W, illustrating the importance of systematic screening of this gene in autoimmune diseases.14 In this study we describe an investigation of SNPs covering the PTPN22 gene region in a case-control association study of U.K. patients with psoriasis.
###end p 14
###begin title 15
Materials and methods
###end title 15
###begin p 16
###xml 76 82 76 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
The study was a case-control candidate gene investigation of markers in the PTPN22 gene region carried out in a two-stage design.
###end p 16
###begin title 17
Stage 1
###end title 17
###begin p 18
###xml 15 23 <span type="species:ncbi:9606">patients</span>
###xml 188 196 <span type="species:ncbi:9606">patients</span>
###xml 338 346 <span type="species:ncbi:9606">patients</span>
###xml 430 438 <span type="species:ncbi:9606">patients</span>
Recruitment of patients with Type I psoriasis for the initial case cohort was coordinated through the Dermatology Centre, Hope Hospital, The University of Manchester, Manchester, U.K. All patients gave written informed consent and the study was approved by the Salford and Trafford Local Research Ethics Committee. In total 647 unrelated patients with Type I psoriasis (53.8% male; 46.2% female; mean age of onset 20 years; 50.9% patients HLA-Cw6 positive) were compared against 566 population-based controls of U.K. white ethnic origin.
###end p 18
###begin title 19
Stage 2
###end title 19
###begin p 20
###xml 243 245 243 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 323 324 323 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 688 690 688 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 33 41 <span type="species:ncbi:9606">patients</span>
A second cohort of 253 unrelated patients with Type I psoriasis (64.8% male; 32.4 female; mean age of onset 21 years) was provided by Guy's Hospital, London, U.K. A further 2088 controls were available from the 1958 British Birth Cohort study.23 These samples were used to evaluate further the SNPs found to be associated (P < 0.05 in both trend and genotypic association tests) in stage 1. The Oversight Committee for the Biomedical Assessment of the British 1958 Birth Cohort Study provided access to the DNA. Genotype data generated from the 64 nonwhite individuals included in the cohort was not included in the analysis, providing a total of 2024 controls (50.1% male; 49.9% female).23
###end p 20
###begin title 21
Single nucleotide polymorphism selection
###end title 21
###begin p 22
###xml 36 42 36 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 351 357 351 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 400 406 400 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Fig. 1</xref>
Seven haplotype-tagging SNPs across PTPN22 were augmented with three potentially functional SNPs, three SNPs with minor allele frequencies of less than 5% to increase the power of detecting association for rare SNPs and an additional SNP that had shown the most significant association to rheumatoid arthritis initially in an investigation by Carlton et al.14 who produced this particular SNP panel (Fig. 1). Assays were designed successfully for 13 of these markers.
###end p 22
###begin p 23
###xml 11 17 11 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
Map of the PTPN22 gene region and approximate location of genotyped SNPs.
###end p 23
###begin title 24
Genotyping
###end title 24
###begin p 25
###xml 54 60 54 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
Thirteen SNPs, including R620W, were genotyped in the PTPN22 region using Sequenom(R) MassArraytrade mark technology according to the manufacturer's instructions using the iPLEX chemistry.
###end p 25
###begin title 26
Statistical analyses
###end title 26
###begin p 27
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
The statistical software package STATA version 8.2 (StataCorp Lp, College Station, TX, U.S.A.) was used to evaluate the differences in allele and genotype frequencies of each SNP between cases and controls and also to test the Hardy Weinberg equilibrium (HWE). Furthermore this software was used to perform stepwise logistic regression on the allelic and genotypic data of the combined dataset. Permutation testing of the data was performed using the PLINK statistical package,24 assessing the empirical significance level of the associations over 10 000 permutations.
###end p 27
###begin title 28
Linkage disequilibrium
###end title 28
###begin p 29
###xml 188 194 179 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 331 332 322 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 332 333 323 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</italic>
###xml 332 333 323 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>2</italic></sup>
The genetic analysis software, HelixTreetrade mark (Golden Helix Incorporated, Bozeman, MT, U.S.A.) was used to calculate the extent of linkage disequilibrium (LD) between the SNPs in the PTPN22 gene region. The parameters used for LD analysis are D', which is a measure of the statistical significance of LD between two SNPs, and r2 which is the square of the correlation between two SNPs.
###end p 29
###begin title 30
Results
###end title 30
###begin title 31
Association testing: stage 1
###end title 31
###begin p 32
###xml 130 131 130 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 162 163 158 159 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 171 172 165 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 189 196 183 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 300 307 294 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 458 459 452 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 606 607 600 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 754 755 748 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1065 1072 1059 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 1192 1193 1186 1187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1251 1258 1245 1252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 369 377 <span type="species:ncbi:9606">patients</span>
###xml 832 839 <span type="species:ncbi:9606">patient</span>
###xml 996 1004 <span type="species:ncbi:9606">patients</span>
In stage 1 of the study, two SNPs (rs1217414 and rs3789604) demonstrated significant genotypic association with Type I psoriasis (P </= 0.05 for both standard chi2 and chi2 test for trend, Table 1). No other SNPs, including R620W, showed evidence of association with Type I psoriasis by these tests (Table 1). The most significant difference in genotype frequencies of patients with Type I psoriasis and controls from stage 1 was observed for SNP rs1217414 (P = 0.0014), where risk was conferred by carriage of two copies of the minor allele (genotype TT) with an odds ratio (OR) = 2.39 (95% CI 1.43-4.11, P = 0.0005). However, the observed genotype frequencies in the controls deviated significantly from the expected number under the HWE for this SNP (P = 0.022). Nonetheless, the associations remained significant when comparing patient genotype frequencies with the expected HWE frequencies for controls. The genotype frequencies of rs3789604 were also significantly different when comparing patients with Type I psoriasis and controls in the initial analysis (Table 1). This association was based on a dominant model of inheritance for the major allele with OR = 1.43 (95% CI 1.13-1.80, P = 0.002) with the trend in frequencies also significant (Table 1) corresponding to an increase in major allele T frequency and TT genotype.
###end p 32
###begin p 33
Genotype frequencies in cases and controls for Type I psoriasis in stage 1 of the study
###end p 33
###begin p 34
Hardy Weinberg equilibrium (HWE) statistic calculated in STATA 8.2 from comparing genotype frequencies expected under HWE against the observed genotype frequencies.
###end p 34
###begin p 35
Genotype failure in the controls.
###end p 35
###begin p 36
SNP, single nucleotide polymorphism.
###end p 36
###begin title 37
Stage 2 and combined analysis
###end title 37
###begin p 38
###xml 87 88 87 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 99 100 99 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 504 505 504 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 515 522 515 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
###xml 647 648 647 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 781 788 781 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
###xml 909 910 907 908 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 918 919 914 915 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 936 937 932 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 973 980 969 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
###xml 1058 1059 1054 1055 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1230 1237 1226 1233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
###xml 156 164 <span type="species:ncbi:9606">patients</span>
###xml 249 257 <span type="species:ncbi:9606">patients</span>
Markers rs1217414 and rs3789604 were genotyped in additional case and control samples (n = 253 and n = 2024, respectively). Because of the small numbers of patients with psoriasis in the second cohort with an approximate 10 : 1 ratio of controls to patients, this additional genotype data was combined with data from stage 1. There was no increased evidence of association of rs1217414 with Type I psoriasis in the combined data sets although the difference in genotype frequency did remain significant (P = 0.003, Table 2) with risk again conferred by carriage of two copies of the minor allele with an odds ratio (OR) of 1.55 (95% CI 1.16-2.08, P = 0.003). Permutation testing of the data showed that the best model remained significant over 10 000 permutations for this marker (Table 2). In the combined data sets an increased evidence of association was obtained for SNP rs3789604 by both the standard chi2 and chi2 test for trend (P = 0.0002 and 0.0001, respectively; Table 2). Association for the dominant model showed an OR of 1.35 (95% CI 1.16-1.58, P = 0.002) for the major allele. Furthermore, the assortment of cases and controls concluded that the association had not occurred by chance following permutation testing (Table 2).
###end p 38
###begin p 39
Genotype frequencies in cases and controls for Type I psoriasis in the combined study
###end p 39
###begin p 40
Hardy Weinberg equilibrium (HWE) statistic calculated in STATA 8.2 from comparing genotype frequencies expected under HWE against the observed genotype frequencies.
###end p 40
###begin p 41
###xml 20 21 20 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Corrected empirical P-value calculated for 10 000 permutations using PLINK software.
###end p 41
###begin p 42
SNP, single nucleotide polymorphism.
###end p 42
###begin title 43
HLA-Cw6 stratification
###end title 43
###begin p 44
###xml 244 245 244 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 287 294 287 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl3">Table 3</xref>
###xml 18 26 <span type="species:ncbi:9606">patients</span>
###xml 54 62 <span type="species:ncbi:9606">patients</span>
###xml 230 238 <span type="species:ncbi:9606">patients</span>
Stratification of patients for HLA-Cw6 status (51% of patients were HLA-Cw6 positive) was performed only at stage 1 of the analysis. Association for rs1217414 and rs3789604 was significant although reduced in the HLA-Cw6 positive patients with P-values of 0.024 and 0.030, respectively (Table 3), suggesting that association of these markers with psoriasis was not dependent on HLA-Cw6 status.
###end p 44
###begin p 45
###xml 24 30 24 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
Genotype frequencies of PTPN22 region single nucleotide polymorphisms (SNPs) in HLA-Cw6 positive cases and controls
###end p 45
###begin p 46
Hardy Weinberg equilibrium (HWE) statistic calculated in STATA 8.2 from comparing genotype frequencies expected under HWE against the observed genotype frequencies.
###end p 46
###begin title 47
Linkage disequilibrium analysis
###end title 47
###begin p 48
###xml 102 108 93 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 117 123 108 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2</xref>
###xml 133 134 124 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 134 135 125 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</italic>
###xml 134 135 125 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>2</italic></sup>
###xml 293 294 284 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 294 295 285 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</italic>
###xml 294 295 285 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>2</italic></sup>
###xml 377 378 368 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 378 379 369 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</italic>
###xml 378 379 369 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>2</italic></sup>
###xml 387 393 378 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2</xref>
###xml 487 488 478 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 488 489 479 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</italic>
###xml 488 489 479 480 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>2</italic></sup>
Analysis of the control cohort using the HelixTreetrade mark software produced pairwise LD across the PTPN22 region (Fig. 2). D' and r2 were measured as parameters for LD structure. LD was detected across the gene with D' > 0.95 for all SNPs excluding ss38346943 and ss383469842. However, the r2 value showed that there were only five combinations of SNPs strongly correlated (r2 > 0.8, Fig. 2). SNPs rs1217414 and rs3789604, the two associated SNPs, demonstrated high D' (0.88) but low r2 (0.06) with each other. A comparison between case and control LD plots showed no major differences in LD structure between the subgroups.
###end p 48
###begin p 49
###xml 51 57 51 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 213 219 204 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 387 388 378 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 388 389 379 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</italic>
###xml 388 389 379 380 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>2</italic></sup>
###xml 620 621 611 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 621 622 612 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</italic>
###xml 621 622 612 613 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>2</italic></sup>
###xml 663 664 654 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 664 665 655 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</italic>
###xml 664 665 655 656 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>2</italic></sup>
Pairwise linkage disequilibrium pattern across the PTPN22 region. The genetic analysis software, HelixTreetrade mark (Golden Helix Incorporated) was used to calculate the extent of LD between both the SNPs in the PTPN22 region. The parameters used for LD analysis are D', which is a measure of the statistical significance of LD between two SNPs reflecting historical recombination; and r2, which is the square of the correlation between two SNPs thus measuring the correlation between alleles at two loci. The extent of LD between any two SNPs in this figure corresponds to the colour scale shown where no LD (D' = 0 / r2 = 0) is white and complete LD (D' = 1 / r2 = 1) is red.
###end p 49
###begin title 50
Stepwise logistic regression
###end title 50
###begin p 51
###xml 209 210 209 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Stepwise logistic regression was conducted on both associated SNPs. The TT genotype of rs3789604 was the only significant variable in the regression model regardless of SNP order; OR = 1.39 (95% CI 1.15-1.68; P = 0.001).
###end p 51
###begin p 52
###xml 141 142 141 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 271 272 271 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Carriage of both associated risk alleles (TT) was associated with a significantly increased risk of psoriasis; OR = 1.16 (95% CI: 1.02-1.33; P = 0.002). Interestingly, carrying neither risk allele (CG) was found to have a protective effect; OR = 0.79 (95% CI: 0.67-0.93; P = 0.0003).
###end p 52
###begin title 53
Discussion
###end title 53
###begin p 54
###xml 4 10 4 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 134 136 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">19</xref>
###xml 295 301 295 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 353 358 353 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RSBN1</italic>
###xml 379 385 379 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 491 492 491 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 520 521 518 519 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 533 534 529 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 865 866 861 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 866 867 862 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</italic>
###xml 866 867 862 863 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>2</italic></sup>
The PTPN22 R620W polymorphism was not associated with Type I psoriasis; this replicated the findings of previous case-control studies.15,16,18,19 However, the investigation did detect an association between psoriasis and two other markers, namely rs1217414 and rs3789604, located in intron 1 of PTPN22 and exon 1 of the round spermatid basic protein 1 (RSBN1) gene downstream of PTPN22, respectively. SNP rs3789604 showed the strongest association with the disease in the combined analysis (P = 0.0002 and 0.0001 for chi2 and the chi2 trend test, respectively), which remained significant after permutation testing. Although the evidence for the association of rs1217414 was not increased in the larger sample size, this remained significant even after permutation testing. LD analysis demonstrated that although D' LD was high between the alleles, LD correlation (r2) between rs1217414 and rs3789604 was low. SNP rs1217414 was excluded from stepwise logistic regression with rs3789604, indicating that there is no additional significant association with Type I psoriasis with this marker conditional on SNP rs3789604. A closer examination of these two markers revealed that 96% of individuals homozygous for the minor allele (TT) for SNP rs1217414 were also homozygous for the major allele (TT) for rs3789604 leading to the masking of rs1217414 by rs3789604 (but not reversed) in the effect on the disease. Carriage of both associated risk alleles (T allele for both rs1217414 and rs3789604) revealed a significantly increased risk of disease while carriage of the opposing alleles (C for rs1217414 and G for rs3789604) demonstrated an even greater protective effect against development of Type I psoriasis.
###end p 54
###begin p 55
###xml 74 76 74 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 301 302 301 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 314 315 314 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 408 414 408 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 485 487 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 651 652 651 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 661 663 661 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 771 777 771 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 782 787 782 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RSBN1</italic>
###xml 1076 1078 1076 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 1111 1117 1111 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 1158 1164 1158 1164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1164 1166 1164 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 1325 1331 1325 1331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 1440 1446 1440 1446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 182 190 <span type="species:ncbi:9606">patients</span>
###xml 237 245 <span type="species:ncbi:9606">patients</span>
The results of this study are supported by the findings of a German study.18 In that study SNP rs2476601 was tested initially in an exploratory case-control study of 375 independent patients who were then combined with an additional 418 patients; there was no association with the R620W polymorphism (P = 0.22 and P = 0.19, respectively). However, the same study revealed psoriasis susceptibility in or near PTPN22 from haplotype analysis of four LD blocks across the region on 1p13.2.18 The common haplotype in three of the four LD blocks was found to be associated with psoriasis with only two remaining significant following Bonferroni correction (P = 0.02).18 Interestingly, the LD blocks containing these associated haplotypes spanned the region containing both the PTPN22 and RSBN1 genes; therefore the possibility remains that the associations detected in this study could be due to LD with other SNPs across the region. Furthermore, the rs3789604 marker has also been associated with rheumatoid arthritis independently of the well-characterized association with R620W.14 Interaction studies between the PTPN22 risk haplotypes identified by Huffmeier et al.18 and HLA-Cw6 returned negative estimates for both associated haplotypes thereby excluding a direct interaction between HLA-Cw6 and the causative allele within PTPN22 for susceptibility to psoriasis. The current study provides further evidence of lack of interaction between PTPN22 and HLA-Cw6.
###end p 55
###begin p 56
###xml 122 127 122 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RSBN1</italic>
###xml 179 185 179 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 410 412 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 516 522 516 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 534 536 534 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 665 668 665 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SHH</italic>
###xml 752 755 752 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SSQ</italic>
###xml 761 768 761 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C6orf26</italic>
###xml 829 832 829 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SHH</italic>
###xml 949 951 949 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 942 948 <span type="species:ncbi:9606">humans</span>
SNP rs3789604 is located in a predicted transcription factor binding site in the 5' end and exonic region (exon 1) of the RSBN1 gene. This marker is 1496 base pairs downstream of PTPN22 where the polymorphism results in either a synonymous mutation or putative transcription binding site.14 The rs3789604 polymorphism lies within a predicted transcription factor binding site for Pax-5, Pax-4, Nrf-1 and c-Myb.14 The minor allele G is believed to alter the binding activity for Pax-4 and Pax-5, which could regulate PTPN22 expression.14 Indeed, there is evidence of regulatory regions lying in adjacent genes, best described in the case of the sonic hedgehog gene (SHH) where a mutation residing approximately 1 Mb away from the gene called sasquatch (SSQ, now C6orf26) interrupts a long-range cis-acting regulator that disrupts SHH regulation and is thought to be responsible for preaxial polydactyly disease (a common limb malformation) in humans.25
###end p 56
###begin p 57
###xml 118 122 118 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PAX5</italic>
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 222 226 222 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PAX5</italic>
###xml 413 415 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">26</xref>
###xml 464 468 464 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PAX5</italic>
###xml 525 527 525 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">27</xref>
###xml 895 901 895 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
The PAX genes are a family of transcription factors which are of primary importance during organogenesis. Furthermore PAX5 encodes the B-cell specific activator protein required for B lymphoid lineage.14 In the absence of PAX5, pro-B cells have the potential to differentiate into functional macrophages, osteoclasts, dendritic cells, granulocytes or natural killer cells depending on the cytokines inducing them,26 with a more recent publication determining that PAX5 functions to determine B- vs. T-cell developmental fate.27 Therefore it is conceivable that the rs3789604 polymorphism determines or initiates T-cell activation at the site of plaques of psoriasis. The SNP rs1217414 found to be associated with Type I psoriasis in this study has not been identified as associated with antibody-associated autoimmune diseases and its exact function is therefore unknown. Located in intron 1 of PTPN22 gene, it may have an effect on gene transcription.
###end p 57
###begin p 58
###xml 169 175 169 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 260 266 260 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
This study confirms that the R620W polymorphism is not associated with Type I psoriasis thereby replicating existing studies. Evidence of association of two SNPs in the PTPN22 gene region with Type I psoriasis susceptibility may suggest that altered levels in PTPN22 transcription may influence T-cell function and thereby influence susceptibility to psoriasis.
###end p 58
###begin p 59
This project was supported by an unrestricted Stiefel PhD studentship, awarded to Rhodri Llywelyn Smith (Stiefel Laboratories, Maidenhead, U.K.). We also acknowledge use of specimens from the British 1958 Birth Cohort DNA collection, funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02.
###end p 59
###begin title 60
References
###end title 60
###begin article-title 61
Pathogenesis and clinical features of psoriasis
###end article-title 61
###begin article-title 62
Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris
###end article-title 62
###begin article-title 63
Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis
###end article-title 63
###begin article-title 64
Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan
###end article-title 64
###begin article-title 65
Genome wide scan in German families reveals evidence for a novel psoriasis-susceptibility locus on chromosome 19p13
###end article-title 65
###begin article-title 66
Identification of a novel psoriasis susceptibility locus at 1p and evidence of epistasis between PSORS1 and candidate loci
###end article-title 66
###begin article-title 67
Evidence for a major psoriasis susceptibility locus at 6p21 (PSORS1) and a novel candidate region at 4q31 by genome-wide scan in Chinese Hans
###end article-title 67
###begin article-title 68
###xml 71 76 <span type="species:ncbi:9606">human</span>
Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q
###end article-title 68
###begin article-title 69
A genome-wide search for genes predisposing to familial psoriasis by using a stratification approach
###end article-title 69
###begin article-title 70
Evidence that a locus for familial psoriasis maps to chromosome 4q
###end article-title 70
###begin article-title 71
###xml 71 79 <span type="species:ncbi:9606">patients</span>
Psoriasis susceptibility locus in chromosome region 3q21 identified in patients from southwest Sweden
###end article-title 71
###begin article-title 72
Genetics of psoriasis in Iceland: evidence for linkage of subphenotypes to distinct loci
###end article-title 72
###begin article-title 73
Getting under the skin: the immunogenetics of psoriasis
###end article-title 73
###begin article-title 74
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
PTPN22 genetic variation: evidence for multiple variants associated with rheumatoid arthritis
###end article-title 74
###begin article-title 75
###xml 100 106 100 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes
###end article-title 75
###begin article-title 76
Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene
###end article-title 76
###begin article-title 77
A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes
###end article-title 77
###begin article-title 78
###xml 76 82 76 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 93 101 <span type="species:ncbi:9606">patients</span>
Evidence for susceptibility determinant(s) to psoriasis vulgaris in or near PTPN22 in German patients
###end article-title 78
###begin article-title 79
###xml 34 40 34 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
Protein tyrosine phosphatase gene PTPN22 polymorphism in psoriasis: lack of evidence for association
###end article-title 79
###begin article-title 80
###xml 56 62 56 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
Male restricted genetic association of variant R620W in PTPN22 with psoriatic arthritis
###end article-title 80
###begin article-title 81
###xml 38 44 38 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
Association of functional variants of PTPN22 and tp53 in psoriatic arthritis: a case-control study
###end article-title 81
###begin article-title 82
Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant
###end article-title 82
###begin article-title 83
###xml 52 57 <span type="species:ncbi:9606">Child</span>
Cohort profile: 1958 British birth cohort (National Child Development Study)
###end article-title 83
###begin article-title 84
PLINK: A tool set for whole-genome association and population-based linkage analyses
###end article-title 84
###begin article-title 85
Disruption of a long-range cis-acting regulator for Shh causes preaxial polydactyly
###end article-title 85
###begin article-title 86
Commitment to the B-lymphoid lineage depends on the transcription factor Pax5
###end article-title 86
###begin article-title 87
Pax5 determines B- versus T-cell fate and does not block early myeloid-lineage development
###end article-title 87

